CHI3L2 has been identified as an inducer of autoimmune processes [84] and chronic inflammatory states such as OA or RA [70,85], as demonstrated by elevated levels of CHI3L2 in the synovial fluid of affected patients. Here, CHI3L2 is linked to rheumatoid arthritis.